Matthias Antz
Matthias Antz has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Dietmar Bänsch
Department of Cardiology , St Georg Hospital , Hamburg , Germany
2 shared publicationsFeifan Ouyang
Department of Cardiology , St Georg Hospital , Hamburg , Germany
2 shared publicationsKr Julian Chun
2 shared publicationsBoris Schmidt
Asklepios Klinik St. Georg, Department of Cardiology, Lohmuhlenstr. 5, 22099 Hamburg, Germany
1 shared publicationFlorian Deger
Department of Cardiology , St Georg Hospital , Hamburg , Germany
1 shared publicationKarl Heinz Kuck
1 shared publication
Latest Publications
- Open Access
- 1 April 2007
- Vol. 7 (2) , 126-133
Pulmonary Vein Isolation by High Intensity Focused Ultrasound
Pulmonary vein isolation (PVI) using radiofrequency current (RFC) ablation is a potentially curative treatment option for patients with atrial fibrillation (AF). The shortcomings of the RFC technology (technically challenging, long procedure times, complications) steadily kindle the interest in new energy sources and catheter designs. High intensity focused ultrasound (HIFU) has the ability to precisely focus ultrasound waves in a defined area with a high energy density. HIFU balloon catheters (BC) positioned at the PV ostia appear to be an ideal tool to transmit the ablation energy in a circumferential manner to the PV ostia and may therefore bear substantial advantage over conventional ablation catheters in PVI procedures.
- 1 April 2007
- Vol. 7 (2) , 126-133
Open AccessPulmonary Vein Isolation by High Intensity Focused Ultrasound
Pulmonary vein isolation (PVI) using radiofrequency current (RFC) ablation is a potentially curative treatment option for patients with atrial fibrillation (AF). The shortcomings of the RFC technology (technically challenging, long procedure times, complications) steadily kindle the interest in new energy sources and catheter designs. High intensity focused ultrasound (HIFU) has the ability to precisely focus ultrasound waves in a defined area with a high energy density. HIFU balloon catheters (BC) positioned at the PV ostia appear to be an ideal tool to transmit the ablation energy in a circumferential manner to the PV ostia and may therefore bear substantial advantage over conventional ablation catheters in PVI procedures.
- 1 March 2007
- Published by Springer Nature in Herz
- Vol. 32 (3) , 233-239
Idiopathic Ventricular Fibrillation
Idiopathic ventricular fibrillation (IVF) is responsible for a sizable part of sudden cardiac death (SCD). Furthermore, it has a high recurrence rate. Recent publications have shown that IVF is often caused by premature ventricular contractions (PVCs) arising from the right ventricular outflow tract (RVOT) or the Purkinje system. Some cases are associated with unbalanced sympathetic cardiac innervation. Some other cases are now believed to be a variant of the Brugada syndrome. Drugs have been shown to be ineffective in the therapy of IVF. The implantable cardioverter defibrillator used to be the only effective therapeutic option. However, radiofrequency (RF) catheter ablation of the trigger (PVCs arising from the RVOT or Purkinje system) has shown to be effective in a considerable number of patients and is now included in the guidelines of secondary prevention of SCD.
- 1 March 2007
- Published by Springer Nature in Herz
- Vol. 32 (3) , 233-239
Idiopathic Ventricular Fibrillation
Idiopathic ventricular fibrillation (IVF) is responsible for a sizable part of sudden cardiac death (SCD). Furthermore, it has a high recurrence rate. Recent publications have shown that IVF is often caused by premature ventricular contractions (PVCs) arising from the right ventricular outflow tract (RVOT) or the Purkinje system. Some cases are associated with unbalanced sympathetic cardiac innervation. Some other cases are now believed to be a variant of the Brugada syndrome. Drugs have been shown to be ineffective in the therapy of IVF. The implantable cardioverter defibrillator used to be the only effective therapeutic option. However, radiofrequency (RF) catheter ablation of the trigger (PVCs arising from the RVOT or Purkinje system) has shown to be effective in a considerable number of patients and is now included in the guidelines of secondary prevention of SCD.
- Open Access
- 1 November 2006
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 8 (11) , 968-976
Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation
Aims For ablation of ventricular tachycardia (VT) in patients after myocardial infarction, a three-dimensional mapping system is often used. We report on our overall success rate of VT ablation using CARTO in 47 patients, with a subgroup analysis comparing VT mapping with the results of mapping that had to be performed during sinus rhythm or pacing (substrate mapping). Methods and results A CARTO map was performed and VT ablation attempted using two strategies: Patients in the VT-mapping group had incessant VT (four patients) or inducible stable VT (18 patients) such that the circuit of the clinical VT could be reconstructed using CARTO. During VT, the critical area of slow conduction was identified using diastolic potentials and conventional concealed entrainment pacing. In contrast, patients in the substrate-mapping group had initially inducible VT. However, a complete VT map was not possible because of catheter-induced mechanical block (six patients) or because haemodynamics deteriorated during the ongoing VT (19 patients). Therefore, pathological myocardium was identified by fragmented, late- and/or low-amplitude (Conclusion When using a CARTO-guided approach for VT ablation in patients with coronary artery disease, the freedom from any ventricular arrhythmia is high (75%), but leaves the patient at a 23% risk of developing fast VT/VF during follow-up. Mapping during sinus rhythm or pacing is as successful as mapping during VT.
- 1 November 2006
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 8 (11) , 968-976
Open AccessSubstrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation
Aims For ablation of ventricular tachycardia (VT) in patients after myocardial infarction, a three-dimensional mapping system is often used. We report on our overall success rate of VT ablation using CARTO in 47 patients, with a subgroup analysis comparing VT mapping with the results of mapping that had to be performed during sinus rhythm or pacing (substrate mapping). Methods and results A CARTO map was performed and VT ablation attempted using two strategies: Patients in the VT-mapping group had incessant VT (four patients) or inducible stable VT (18 patients) such that the circuit of the clinical VT could be reconstructed using CARTO. During VT, the critical area of slow conduction was identified using diastolic potentials and conventional concealed entrainment pacing. In contrast, patients in the substrate-mapping group had initially inducible VT. However, a complete VT map was not possible because of catheter-induced mechanical block (six patients) or because haemodynamics deteriorated during the ongoing VT (19 patients). Therefore, pathological myocardium was identified by fragmented, late- and/or low-amplitude (Conclusion When using a CARTO-guided approach for VT ablation in patients with coronary artery disease, the freedom from any ventricular arrhythmia is high (75%), but leaves the patient at a 23% risk of developing fast VT/VF during follow-up. Mapping during sinus rhythm or pacing is as successful as mapping during VT.
- 14 August 2006
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 17 (11) , 1242-1245
Ablation of Atrial Fibrillation in Humans Using a Balloon‐Based Ablation System: Identification of the Site of Phrenic Nerve Damage Using Pacing Maneuvers and CARTO
Injury of the phrenic nerve during pulmonary vein isolation for the treatment of atrial fibrillation is a well‐recognized complication, especially when performing ostial ablations or using balloon‐based technologies. This report describes the exact anatomical location of phrenic nerve injury during an attempt of right superior pulmonary vein isolation using a balloon that delivered high intensity focused ultrasound. Electroanatomical three‐dimensional CARTO (Biosense Webster, Diamond Bar, CA, USA) mapping of the superior caval vein, the right and left atrium, as well as the right superior pulmonary vein was performed in conjunction with meticulous phrenic nerve pacing maneuvers before and after ablation and showed that the nerve was damaged at the level of the antero‐inferior ostium of the right superior pulmonary vein. Diaphragmatic denervation occurred despite using an oversized balloon fluoroscopically placed at the atrial side of the pulmonary vein ostium.
- 14 August 2006
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 17 (11) , 1242-1245
Ablation of Atrial Fibrillation in Humans Using a Balloon‐Based Ablation System: Identification of the Site of Phrenic Nerve Damage Using Pacing Maneuvers and CARTO
Injury of the phrenic nerve during pulmonary vein isolation for the treatment of atrial fibrillation is a well‐recognized complication, especially when performing ostial ablations or using balloon‐based technologies. This report describes the exact anatomical location of phrenic nerve injury during an attempt of right superior pulmonary vein isolation using a balloon that delivered high intensity focused ultrasound. Electroanatomical three‐dimensional CARTO (Biosense Webster, Diamond Bar, CA, USA) mapping of the superior caval vein, the right and left atrium, as well as the right superior pulmonary vein was performed in conjunction with meticulous phrenic nerve pacing maneuvers before and after ablation and showed that the nerve was damaged at the level of the antero‐inferior ostium of the right superior pulmonary vein. Diaphragmatic denervation occurred despite using an oversized balloon fluoroscopically placed at the atrial side of the pulmonary vein ostium.
- 1 February 2005
- Published by Springer Nature in Herz
- Vol. 30 (2) , 87-90
Dilatative Kardiomyopathie—wohin schlägt das Pendel aus?
- 1 February 2005
- Published by Springer Nature in Herz
- Vol. 30 (2) , 87-90
Dilatative Kardiomyopathie—wohin schlägt das Pendel aus?